These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 11896410)

  • 41. Chagas seropositive donors in kidney transplantation.
    Sousa AA; Lobo MC; Barbosa RA; Bello V
    Transplant Proc; 2004 May; 36(4):868-9. PubMed ID: 15194296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serologic evaluation of treatment of chronic Chagas disease with allopurinol and itraconazole].
    Zulantay I; Apt W; Rodríguez J; Venegas J; Sánchez G
    Rev Med Chil; 1998 Mar; 126(3):265-70. PubMed ID: 9674295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New advances in the management of a long-neglected disease.
    Urbina JA
    Clin Infect Dis; 2009 Dec; 49(11):1685-7. PubMed ID: 19877968
    [No Abstract]   [Full Text] [Related]  

  • 44. [Treatment of Chagas disease with benznidazole and thioctic acid].
    Sosa-Estani S; Armenti A; Araujo G; Viotti R; Lococo B; Ruiz Vera B; Vigliano C; de Rissio AM; Segura EL
    Medicina (B Aires); 2004; 64(1):1-6. PubMed ID: 15034949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tolerance of benznidazole in a United States Chagas Disease clinic.
    Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK
    Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Integral treatment of congenital Chagas disease: the Bolivian experience ].
    Suárez E; Alonso-Vega C; Torrico F; Córdova M
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():21-3. PubMed ID: 16482807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
    Coura JR; de Abreu LL; Willcox HP; Petana W
    Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chagas disease and immunodeficiency: HIV infection and transplantation].
    Le Loup G; Ibrahim K; Malvy D
    Bull Soc Pathol Exot; 2009 Dec; 102(5):310-8. PubMed ID: 20131425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres.
    Crespillo-Andújar C; López-Vélez R; Trigo E; Norman F; Díaz-Menéndez M; Monge-Maillo B; Arsuaga M; Pérez-Molina JA
    Clin Microbiol Infect; 2020 Mar; 26(3):384.e1-384.e4. PubMed ID: 31740423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanotechnological approaches against Chagas disease.
    Romero EL; Morilla MJ
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):576-88. PubMed ID: 19941920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of benznidazole as a Chagas disease therapeutic.
    Caldas IS; Santos EG; Novaes RD
    Expert Opin Pharmacother; 2019 Oct; 20(15):1797-1807. PubMed ID: 31456439
    [No Abstract]   [Full Text] [Related]  

  • 53. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.
    Vallejo A; Monge-Maillo B; Gutiérrez C; Norman FF; López-Vélez R; Pérez-Molina JA
    Acta Trop; 2016 Dec; 164():117-124. PubMed ID: 27619190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutiérrez, Buenos Aires, Argentina].
    Altcheh J; Biancardi M; Lapeña A; Ballering G; Freilij H
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():41-5. PubMed ID: 16482812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current and developing therapeutic agents in the treatment of Chagas disease.
    Apt W
    Drug Des Devel Ther; 2010 Sep; 4():243-53. PubMed ID: 20957215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance of benznidazole in treatment of Chagas' disease in adults.
    Pinazo MJ; Muñoz J; Posada E; López-Chejade P; Gállego M; Ayala E; del Cacho E; Soy D; Gascon J
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4896-9. PubMed ID: 20823286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution.
    Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA
    Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report.
    Corrêa VR; Barbosa FG; Melo Junior CA; D'Albuquerque e Castro LF; Andrade Junior HF; Nascimento N
    Rev Soc Bras Med Trop; 2014; 47(3):397-400. PubMed ID: 25075496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up of a patient since the acute phase of Chagas disease (South American trypanosomiasis): further treatment and cure of the infection.
    Dias JC; Dias E; Nóbrega GC
    Rev Soc Bras Med Trop; 2015; 48(5):629-32. PubMed ID: 26516979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease.
    Sosa Estani S; Segura EL; Ruiz AM; Velazquez E; Porcel BM; Yampotis C
    Am J Trop Med Hyg; 1998 Oct; 59(4):526-9. PubMed ID: 9790423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.